Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle‐Based Vaccines for Cancer Immunotherapy
Narumi Harada(Kumamoto University), Toshiro Moroishi(Kumamoto University)
Cited by 1
Related Papers
Hippo pathway in cancer cells induces NCAM1+αSMA+ fibroblasts to modulate tumor microenvironment
|Communications Biology|2024|11
Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy
|Communications Medicine|2025|2